Shares of Bio-Techne Co. (NASDAQ:TECH – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the eight ratings firms that are covering the stock, Marketbeat.com reports.
Bio-Techne Corporation (NASDAQ: TECH), a leader in automated platforms for biotherapeutic characterization, today announced a co-marketing and co-promotion agreement with Waters Corporation aimed at ...
View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-to-present-at-the-43rd-annual-jp-morgan-healthcare-conference ...
Bio-Techne Corporation (TECH), headquartered in Minneapolis, Minnesota, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics ...